Researcher of the Month: Dr. Hannah Chen
How did you get interested in your scientific work? My background is in virus engineering and cancer. I became interested in immunotherapy for treating solid tumours and realised that in order to develop efficacious therapies, I must first gain an understanding of how the immune system becomes dysfunctional in disease settings, such as chronic inflammation and cancer.
I'm most interested in how peripheral tolerance induction occurs and how tumour immunosurveillance becomes subverted during cancer progression.
Q: What are you working on now?
I am studying the phosphatase network regulating PI3K signalling in regulatory T cells. I am also working with T and B cells from patients with a dysregulated PI3K signalling pathway and studying the effects of isoform-selective PI3K inhibition. The goal is to validate the use of small molecule inhibitors to restore the balance of this pathway, therefore reducing the clinical symptoms of PI3K dysregulation.
Q: What do you enjoy the most about working in science?
I enjoy testing new ideas and trying to find a therapeutic angle in everything I study. For me translational research is very important and I can't feel excited about a project unless I can see a potential therapeutic application. In our laboratory, we are able to work with patient samples to investigate the underlying mechanisms of disease, and in doing so we also hope to find treatments for those patients. This makes the hard work worthwhile.
-
News & Events
- Blenheim Fun Run 2017
- Curiosity Carnival
- International Clinical Trials Day, May 20th 2017
- The TGU welcomes STEM Apprentice Placements this summer!
- A word from Prof. Paul Klenerman, the new Sidney Truelove Professor of Gastroenterology
- TGU at the BBSRC Great British Bioscience Festival
- Members of the Powrie group publish in Nature an important new role of IL-33
- NDM Scientists at Royal Society summer exhibition
- TGU at the Royal Society Summer Science Exhibition 2014
- TGU at the Royal Society Summer Exhibition
- BRC3 Gastro RMF Application form
- Clinician-Scientists in the making visit the TGU from the Chinese University of Hong Kong
- Launch event: Human Iron Research at Oxford (HIRO)
- Detailed map of colon cells in health and disease
- New grant to study the role of immune cells in lung regeneration
- NDM's Translational Gastroenterology Unit awarded a CRUK Primer grant of £100,000
- NDM Researchers elected Fellows of the Academy of Medical Sciences
- Oxfordshire Research League Tables
- Memorial Service - Professor Satish Keshav
- Tackling inflammatory bowel disease
- Human Immune Discovery Initiative (HIDI)
- The Good Doctors Guide: Meet the best doctors for gall bladder and learn the cutting-edge treatments for inflammatory bowel disease
- forCrohn's Heroes 2018
- TGU Awards, Grants and Prizes Sep-Oct 2016
- BRC - How Vital Funding Makes a Difference
- Falk Foundation Symposium - 29-30 Mar 2019
- Dietary Fibre Metabolite Helps Immune System Fight Invasive Bacteria
- Professor Satish Keshav
- High Sheriff Award
- FALK Symposium Poster First Prize Winner!
- TGU@10 - 10 Years Celebration Event!
- OUH Quality Improvement Symposium (QIP)
- TGU, University of Oxford Awarded the IBD Stress Test QuickFire Challenge
- OUH NURSE WINS NATIONAL AWARD
- Crohn's Disease and Ulcerative Colitis - Public Information Event April 2021
- The Changing Face of Inflammatory Bowel Disease- Progress in Research and Clinical Care
- Oxford IBD MasterClass 2024 – Personalising care in IBD
- Shortlist Announced for Staff Awards
- NIHR Senior Research Fellows Awards
- Translational Gastroenterology Unit – Logo and Name Update
- Research
- TGLU Biobank/IBD Cohort
- Training Opportunities
- Publications
- TGLU Podcasts
- Links for TGLU Members
- Meet the Team
- Oxford IBD MasterClass 2024